8th Annual Personalized & Precision Medicine Conference

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
8th Annual Personalized & Precision Medicine Conference 2016 - San Francisco, United States - October 12-13, 2016

Dublin, Aug. 17, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "8th Annual Personalized & Precision Medicine Conference " conference to their offering. One of the longest running conferences in the personalized/precision medicine space, this 8th Annual Personalized & Precision Medicine Conference is once again returning to the San Francisco Bay Area, on October 12th-13th.

With the renewed focus on precision medicine stemming from President Obama's 2015 initiative and multiple advances in the field on a variety of fronts, this year's conference promises to expand your thinking and put you front and center to hear from key players and stakeholders in the field. Eight years ago the Personalized & Precision Medicine Conference focused almost exclusively on the one-on-one relationship between the pharmaceutical and diagnostic industries. Since then the field has evolved to encompass not just these bilateral relationships, but multi-stakeholder, precompetitive consortia between the industries that demonstrate their continued commitment to precision medicine and the novel ways in which they are approaching the space.

This year's conference will continue to examine the components that are integral to driving precision medicine into the future, including: - Optimizing Coding and Reimbursement - Laboratory Developed Test (LDT) Regulation - Data Privacy - Innovative Partnerships Furthering Precision Medicine - Crowd Sourcing Therapies - Truly Individualizing Therapy - Ethical/social/legal issues - Transforming data into actionable guidance in the clinic - Weighing clinical utility - Personalized medicine at the bedside - Payor evaluation of next gen sequencing - Aligning labs, clinicians and payers - Development of genomic medicine programs Why Attend?

- PRESENTATIONS from Physicians, Researchers, Reimbursement Experts, Payers and Leaders from the Molecular Diagnostics, Biopharmaceutical and Genome Interpretation Industries - PANEL DISCUSSIONS covering a variety of topics of interest to stakeholders in personalized medicine - Numerous NETWORKING OPPORTUNITIES aided by a pre-conference online networking suite Networking Opportunities

Attendees will have the opportunity to meet other attendees through the following networking services:

- The CONFERENCE NETWORKING SITE is online weeks prior to the event. Attendees can schedule one-on-one meetings prior to the conference and print out a schedule of meeting times during the conference. - EXTENDED NETWORKING BREAKS. These will give attendees the chance to meet those with whom they many not have set up meetings. - EVENING RECEPTION. This will give attendees the chance to mingle with other professionals after a day full of speakers, meetings, and thought-provoking topics. - SPEAKER Q&A SESSIONS. This will afford attendees the opportunity to ask additional questions of our speakers. Key Themes Practicing Precision Medicine. Speakers and panelists will illustrate how physicians are incorporating genetic data into the treatment of various diseases and will discuss what the challenges are in bringing more genetically-guided therapy into the clinic. Companion Diagnostics. Speakers and panelists will provide case studies exploring how diagnostics companies/developers of biomarkers and labs are working with drug developers to bring to market new companion diagnostics and targeted therapies to ensure greater efficacy and thus better patient outcomes. Genomic Data: Infrastructure, Interpretation & Outcomes. Next generation, exome, and whole genome sequencing are accelerating the creation of even more data whose use is critical to the growth of personalized medicine. Speakers and panelists will explore clinical, ethical, technological and business strategy issues related to data collection, sharing and use in the context of the growth needs for personalized medicine. Emerging Reimbursement Policies. Speakers and panelists will discuss the challenges that still exist in terms of reimbursement of molecular diagnostics and lab-developed tests which help guide personalized healthcare. Insurers and reimbursement experts will present their viewpoints and analysis of emerging policies regarding personalized medicine. For more information about this conference visit http://www.researchandmarkets.com/research/r7q6v4/8th_annual Related Topics: Genomics

Other Packages Available

8th Annual Personalized & Precision Medicine Conference - Student Edition 8th Annual Personalized & Precision Medicine Conference - Academic/Government/Non-Profit

CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 445

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 222

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 198

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 216

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 163

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 152

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 306

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 392

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 410

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 314

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading

Top 5 Most Recently Viewed Articles

Globant's 2025 Q1 Revenue Growth and Strategic Focus

Updated Category News Views 873

Globant's Remarkable Financial Performance for Q1 2025 Globant (NYSE: GLOB), a leader in technology-enabled business transformation, has reported a strong performance for the first quarter of 2025. The company achieved revenues of $611.1 million, marking a 7.0% increase compared to the same period last year. This notable growth reflects Globant's commitment to leveraging...

Continue Reading
Transforming Rehabilitation: The Future of Medical Exoskeletons

Updated Category News Views 329

Explosive Growth in the Medical Exoskeleton Market The global medical exoskeleton market is experiencing remarkable growth, projected to reach a value increase of USD 2.87 billion during the upcoming period from 2024 to 2028. A crucial driving force behind this surge is the rising number of spinal cord injury (SCI) cases, coupled with advancements in artificial...

Continue Reading
Exclusive Elks Hoop Shoot Champions Honored at Hall of Fame

Updated Category News Views 167

Celebrating Youth Basketball Talent The spirit of perseverance and hard work was palpable as the finest youth free-throw shooters gathered at Wintrust Arena, illustrating their dedication to the game. Recently, the Elks Hoop Shoot competition showcased young athletes' skills and determination as they vied for national titles in three age groups for both boys and girls....

Continue Reading
Key Insights for Cepton, Inc. Investors Regarding Legal Actions

Updated Category News Views 190

Understanding Your Legal Rights as a Cepton, Inc. Investor Cepton, Inc. (NASDAQ: CPTN) has recently come under scrutiny, attracting the attention of investors concerned about potential securities fraud. As such, it is crucial for shareholders to be informed about their rights and options as they navigate these turbulent waters. Recent developments suggest that investors...

Continue Reading
Teamsters at Seattle Airport Vote to Strike Against Swissport

Updated Category News Views 283

Teamsters at Seattle Airport Take Bold Action In a significant move toward ensuring safe and fair labor practices, air fuelers at Seattle-Tacoma International Airport have voted unanimously to authorize a strike against Swissport, a leading provider of ground services in the aviation industry. With over 150 workers represented by Teamsters Local 174, this decision stems...

Continue Reading